AU2001293891A1 - New combination for the treatment of asthma - Google Patents
New combination for the treatment of asthmaInfo
- Publication number
- AU2001293891A1 AU2001293891A1 AU2001293891A AU9389101A AU2001293891A1 AU 2001293891 A1 AU2001293891 A1 AU 2001293891A1 AU 2001293891 A AU2001293891 A AU 2001293891A AU 9389101 A AU9389101 A AU 9389101A AU 2001293891 A1 AU2001293891 A1 AU 2001293891A1
- Authority
- AU
- Australia
- Prior art keywords
- asthma
- treatment
- new combination
- new
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000006673 asthma Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20002177A FI20002177A0 (en) | 2000-10-02 | 2000-10-02 | New combination for asthma therapy |
| FI20002177 | 2000-10-02 | ||
| PCT/FI2001/000854 WO2002028368A1 (en) | 2000-10-02 | 2001-10-01 | New combination for the treatment of asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001293891A1 true AU2001293891A1 (en) | 2002-04-15 |
Family
ID=8559216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001293891A Abandoned AU2001293891A1 (en) | 2000-10-02 | 2001-10-01 | New combination for the treatment of asthma |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2001293891A1 (en) |
| FI (1) | FI20002177A0 (en) |
| WO (1) | WO2002028368A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| EP1572217B1 (en) | 2002-12-12 | 2008-08-20 | Nycomed GmbH | Combination medicament of r,r-formoterol and ciclesonide |
| GB0312148D0 (en) | 2003-05-28 | 2003-07-02 | Aventis Pharma Ltd | Stabilized pharmaceutical products |
| SE527069C2 (en) | 2003-06-19 | 2005-12-13 | Mederio Ag | Method and apparatus for administering drug powder |
| GB0315889D0 (en) * | 2003-07-08 | 2003-08-13 | Aventis Pharma Ltd | Stable pharmaceutical products |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| US8371292B2 (en) | 2003-09-16 | 2013-02-12 | Nycomed Gmbh | Use of ciclesonide for the treatment of respiratory diseases |
| CN101155590A (en) | 2005-02-10 | 2008-04-02 | 葛兰素集团有限公司 | Method for preparing lactose using a pre-sorting technique and pharmaceutical formulations formed thereby |
| EP1982709A1 (en) * | 2007-04-19 | 2008-10-22 | CHIESI FARMACEUTICI S.p.A. | Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma |
| EP2022798A1 (en) | 2007-08-09 | 2009-02-11 | CHIESI FARMACEUTICI S.p.A. | Synthetic pulmonary surfactant peptides |
| EP2080508A1 (en) * | 2008-01-15 | 2009-07-22 | CHIESI FARMACEUTICI S.p.A. | Dry powder formulation comprising an anticholinergic drug |
| PL2821061T3 (en) * | 2013-07-01 | 2018-05-30 | Arven Ilac Sanayi Ve Ticaret A.S. | Novel inhalation formulations |
| US20190076607A1 (en) | 2017-09-13 | 2019-03-14 | Lupin Atlantis Holdings Sa | Inhaler and mesh for an inhaler |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant |
| SE9700135D0 (en) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| NZ337443A (en) * | 1997-03-20 | 2001-04-27 | Schering Corp | Preparation of powder agglomerates for the production of agglomerated dosage forms suitable for oral and/or nasal inhalation especially for pharmaceuticals of particle size less than 10 microns forming an inter particle bridge between agglomerates |
| HU230804B1 (en) * | 2000-05-22 | 2018-06-28 | Chiesi Farmaceutici S.P.A | Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
-
2000
- 2000-10-02 FI FI20002177A patent/FI20002177A0/en unknown
-
2001
- 2001-10-01 AU AU2001293891A patent/AU2001293891A1/en not_active Abandoned
- 2001-10-01 WO PCT/FI2001/000854 patent/WO2002028368A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| FI20002177A0 (en) | 2000-10-02 |
| WO2002028368A1 (en) | 2002-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002223827A1 (en) | Well treatment | |
| AU2002348135A1 (en) | Methods for the treatment of addiction | |
| AU2002224927A1 (en) | Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds | |
| AU2002223028A1 (en) | Inhaler | |
| AU2002359163A1 (en) | New use | |
| AU2001272852A1 (en) | Composition for the treatment of migraine | |
| AU2002219229A1 (en) | Means for the diagnosis and therapy of CTCL | |
| AU2002210385A1 (en) | Furazanyl-triazole derivates for the treatment of diseases | |
| AU2001249262A1 (en) | Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof | |
| AU2001293891A1 (en) | New combination for the treatment of asthma | |
| AU2001260834A1 (en) | The treatment of herpes | |
| AU2002335667A1 (en) | Modified reoviral therapy | |
| AU2001285156A1 (en) | Combination therapy for the treatment of migraine | |
| AU2002258798A1 (en) | Methods for the treatment of hepatic disorders | |
| AU2003269257A1 (en) | Use of cap-1 for the therapy of asthma | |
| AU2002329441A1 (en) | Process for the preparation of 3 - isochromanone | |
| AU2002343100A1 (en) | The use of metal-chelating adsorbents | |
| AU2002358085A1 (en) | Process for the preparation of 4-methyl-7-aminoquinolones | |
| AU3071899A (en) | Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma | |
| AU5462901A (en) | Process for the preparation of (pyridinylidene)-phthalides | |
| AU2000272704A1 (en) | Use of compounds for the treatment of obesity | |
| AU2001253560A1 (en) | Methods of treatment | |
| AU2001292897A1 (en) | Novel therapy | |
| AU2001258330A1 (en) | New uses of imidazolylmethyl-pyridines | |
| AU2002324291A1 (en) | Process for the preparation of beta-ionylideneacetaldehyde |